abstract |
The present invention provides a method for treating structural heart diseas e in a subject, comprising administering an effective amount of an inhibitor o f CaMKII to the subject, whereby the administration of the inhibitor treats th e structural heart disease in the subject. Also provided are transgenic animal models for treating structural heart disease. Further provided is a means of screening for a compound that can treat structural heart disease. |